Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-19 Sale |
2021-02-22 8:09 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
2,734 | $39.25 | $107,310 | 39,812 (Direct) |
View |
| 2021-02-19 Sale |
2021-02-22 8:07 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
5,184 | $39.22 | $203,308 | 67,617 (Direct) |
View |
| 2021-02-19 Sale |
2021-02-22 8:05 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
10,442 | $39.23 | $409,625 | 20,886 (Direct) |
View |
| 2021-02-19 Sale |
2021-02-22 8:03 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
11,139 | $39.24 | $437,133 | 22,278 (Direct) |
View |
| 2021-02-19 Sale |
2021-02-22 8:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
27,847 | $39.23 | $1,092,436 | 1,189,087 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-12 7:07 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
4,367 | $32.12 | $140,259 | 30,577 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-12 7:06 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
9,684 | $32.02 | $310,082 | 60,332 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-12 7:05 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
19,638 | $32.02 | $628,769 | 19,639 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-12 7:03 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
19,638 | $32.03 | $628,978 | 19,639 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-12 7:01 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
41,896 | $32.01 | $1,341,260 | 1,175,288 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 6:13 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
15,810 | $31.31 | $495,008 | 350 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 6:11 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
16,160 | $31.3 | $505,834 | 0 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-05 6:09 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
48,341 | $31.3 | $1,513,271 | 1,133,392 (Direct) |
View |
| 2020-11-17 Sale |
2020-11-19 8:05 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
79,425 | $27.62 | $2,193,446 | 25,000 (Direct) |
View |
| 2020-11-11 Sale |
2020-11-13 5:51 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
28,034 | $25.41 | $712,344 | 0 (Direct) |
View |
| 2020-11-10 Sale |
2020-11-12 5:51 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
50,000 | $26.34 | $1,317,101 | 1,113,392 (Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 6:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
50,000 | $25 | $1,250,000 | 1,163,392 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-16 4:04 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
6,792 | $26.8 | $182,026 | 41,568 (Direct) |
View |
| 2020-09-14 Purchase |
2020-09-14 5:03 pm |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
49,500 | $29.6 | $1,465,200 | 5,762,746 (Indirect Direct) |
View |
| 2020-09-09 Sale |
2020-09-11 7:08 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
41,983 | $31.14 | $1,307,351 | 62,002 (Direct) |
View |
| 2020-09-11 Purchase |
2020-09-11 4:15 pm |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
21,000 | $28.08 | $589,680 | 5,713,246 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-23 Option Award |
2021-02-25 4:28 pm |
N/A 2031-02-22 |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
42,433 | $0 | 42,433 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 4:24 pm |
N/A 2031-02-22 |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
42,433 | $0 | 42,433 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 4:20 pm |
N/A 2031-02-22 |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
40,008 | $0 | 40,008 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 4:12 pm |
N/A 2031-02-22 |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
42,433 | $0 | 42,433 (Direct) |
View |
| 2021-02-23 Option Award |
2021-02-25 4:01 pm |
N/A 2031-02-22 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
121,240 | $0 | 121,240 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-22 8:09 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
8,354 | $0 | 39,812 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-22 8:07 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
11,139 | $0 | 67,617 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-22 8:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
10,442 | $0 | 20,886 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-22 8:03 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
11,139 | $0 | 22,278 (Direct) |
View |
| 2021-02-18 Exercise |
2021-02-22 8:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
27,847 | $0 | 1,189,087 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 7:07 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
13,092 | $0 | 30,577 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 7:06 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
20,948 | $0 | 60,332 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 7:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
19,638 | $0 | 19,639 (Direct) |
View |
| 2021-01-08 Gift |
2021-01-12 7:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
350 | $0 | 19,639 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 7:03 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
19,638 | $0 | 19,639 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 7:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
41,896 | $0 | 1,175,288 (Direct) |
View |
| 2021-01-03 Exercise |
2021-01-05 6:13 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
16,160 | $0 | 350 (Direct) |
View |
| 2021-01-03 Exercise |
2021-01-05 6:11 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
16,160 | $0 | 0 (Direct) |
View |
| 2021-01-03 Exercise |
2021-01-05 6:09 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
34,341 | $0 | 1,133,392 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 6:07 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
471 | $31.8 | 106,882 (Indirect) |
View |
| 2020-12-31 Option Award |
2021-01-05 6:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
222 | $31.8 | 8,065 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 6:03 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
495 | $31.8 | 288,147 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 6:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
495 | $31.8 | 5,763,854 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-21 4:03 pm |
N/A 2020-12-21 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
34,000 | $0 | 1,147,392 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-21 4:03 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
34,000 | $2.74 | 1,147,392 (Direct) |
View |
| 2020-12-17 Gift |
2020-12-18 4:07 pm |
N/A 2025-06-16 |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
108,379 | $0 | 1,298,675 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 8:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
75,000 | $13.86 | 25,000 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 8:05 pm |
N/A 2024-07-29 |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
75,000 | $0 | 25,000 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-13 5:51 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
10,000 | $2.84 | 0 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-13 5:51 pm |
N/A 2022-04-30 |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
20,000 | $0 | 0 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-13 5:51 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
10,000 | $3.26 | 0 (Direct) |
View |
Ownership |
2020-10-28 4:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
0 | $0 | 209,698 (Direct) |
View |
| 2020-10-15 Exercise |
2020-10-16 4:04 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
13,448 | $0 | 41,568 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 4:24 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
276 | $25.66 | 7,843 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 4:22 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
613 | $25.66 | 287,652 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 4:17 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
584 | $25.66 | 106,411 (Indirect) |
View |
| 2020-09-30 Option Award |
2020-10-02 4:13 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
613 | $25.66 | 5,763,359 (Direct) |
View |
| 2020-09-09 Exercise |
2020-09-11 7:08 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
26,983 | $12.73 | 62,002 (Direct) |
View |
| 2020-09-09 Exercise |
2020-09-11 7:08 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
26,983 | $0 | 62,002 (Direct) |
View |
| 2020-07-08 Gift |
2020-07-10 5:48 pm |
N/A 2024-06-30 |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
20,000 | $0 | 0 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 7:12 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
275 | $25.67 | 7,567 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 7:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
584 | $25.67 | 105,827 (Indirect) |
View |